ImmuONE provides translation studies, high content analysis, immune response, and interaction services.
ImmuONE has raised $777K in total funding. The most recent round was Seed. The last funding was announced in March 2025.
ImmuONE's investors include Mercia Ventures, Midlands Engine Investment Fund, Pioneer Group, MEIF Proof-of-Concept & Early Stage Fund, Mercia's EIS funds.
ImmuONE is headquartered in Hatfield, United Kingdom.
ImmuONE provides translation studies, high content analysis, immune response, and interaction services.
ImmuONE is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"ImmuONE — Funding & Investors." VCBacked, March 13, 2025, https://www.vcbacked.co/company/immuone. Accessed August 14, 2026.
VCBacked. (2025). ImmuONE — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/immuone
{{cite web |title=ImmuONE — Funding & Investors |url=https://www.vcbacked.co/company/immuone |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated